These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 29593912

  • 1. Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.
    Leelasupasri S, Santimaleeworagun W, Jitwasinkul T.
    J Pathog; 2018; 2018():3893492. PubMed ID: 29593912
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
    Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW.
    Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):890-900. PubMed ID: 22299471
    [Abstract] [Full Text] [Related]

  • 3. Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?
    Saelim W, Changpradub D, Thunyaharn S, Juntanawiwat P, Nulsopapon P, Santimaleeworagun W.
    Infect Chemother; 2021 Mar; 53(1):128-140. PubMed ID: 34409786
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A, Ceylan MR, Parlak M, Karahocagil MK, Berktaş M.
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [Abstract] [Full Text] [Related]

  • 5. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H, Kus H, Arslan U, Tuncer I.
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH, Wang JT, Li SY, Lin YC, Cheng A, Chen YC, Chang SC.
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.
    Thamlikitkul V, Tiengrim S.
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y, Telli M, Altunçekiç Yıldırım A, Çalgın MK.
    Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
    [Abstract] [Full Text] [Related]

  • 9. Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant Acinetobacter baumannii Strains.
    Sertcelik A, Baran I, Akinci E, Mumcuoglu I, Bodur H.
    Microb Drug Resist; 2020 May; 26(5):429-433. PubMed ID: 31657659
    [Abstract] [Full Text] [Related]

  • 10. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
    Fan B, Guan J, Wang X, Cong Y.
    PLoS One; 2016 May; 11(6):e0157757. PubMed ID: 27315107
    [Abstract] [Full Text] [Related]

  • 11. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
    Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B.
    J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V.
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial Susceptibilities of Clinical Acinetobacter baumannii Isolates With Different Genotypes.
    Altun HU, Yagci S, Bulut C, Sahin H, Kinikli S, Adiloglu AK, Demiroz AP.
    Jundishapur J Microbiol; 2014 Dec; 7(12):e13347. PubMed ID: 25741433
    [Abstract] [Full Text] [Related]

  • 14. In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques.
    Soudeiha MAH, Dahdouh EA, Azar E, Sarkis DK, Daoud Z.
    Front Cell Infect Microbiol; 2017 Dec; 7():209. PubMed ID: 28596943
    [Abstract] [Full Text] [Related]

  • 15. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I, Zer Y, Bosnak VK, Mete AO, Namiduru M.
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [Abstract] [Full Text] [Related]

  • 16. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C, Xie W, Zhang W, Ye Z, Wu H.
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [Abstract] [Full Text] [Related]

  • 17. In vitro evaluation of antimicrobial combinations against imipenem-resistant Acinetobacter baumannii of different MICs.
    Zhu W, Wang Y, Cao W, Cao S, Zhang J.
    J Infect Public Health; 2018 Apr; 11(6):856-860. PubMed ID: 30057349
    [Abstract] [Full Text] [Related]

  • 18. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii.
    Marie MA, Krishnappa LG, Alzahrani AJ, Mubaraki MA, Alyousef AA.
    Bosn J Basic Med Sci; 2015 Oct 14; 15(4):24-9. PubMed ID: 26614848
    [Abstract] [Full Text] [Related]

  • 19. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
    Wang YC, Kuo SC, Yang YS, Lee YT, Chiu CH, Chuang MF, Lin JC, Chang FY, Chen TL.
    Antimicrob Agents Chemother; 2016 Aug 14; 60(8):4670-6. PubMed ID: 27216052
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
    Pei G, Mao Y, Sun Y.
    Microb Drug Resist; 2012 Dec 14; 18(6):574-7. PubMed ID: 22928863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.